Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

J&J regulatory affairs: Robert O'Holla retires in April from his position as VP-regulatory affairs for Johnson & Johnson's device and diagnostics segments after more than 30 years with the company. O'Holla has held his current position since 1990. Dorothy Clarke has been transitioning to fill his role since February, with the new title of VP-regulatory affairs for the Comprehensive Care and Surgical Care units, housing most of J&J's device businesses following a restructuring last November (1"The Gray Sheet" Nov. 19, 2007, p. 11). Clarke was previously a legal VP at Ethicon and assistant general counsel for the J&J device and diagnostics legal group

You may also be interested in...



People In Brief

Eucomed: The European medical technology industry association approved a new board of directors April 13. Guy Lebeau, Johnson & Johnson's Medical Device and Diagnostics company group chairman for Europe, Middle East and Africa, was reelected as chairman. Alain Coudray, Medtronic's VP for Cardiac Rhythm Disease Management, Europe and Central Asia, is the new vice chairman. The board is composed of 15 members, including five corporate representatives and seven representatives of individual European country associations

People In Brief

Eucomed: The European medical technology industry association approved a new board of directors April 13. Guy Lebeau, Johnson & Johnson's Medical Device and Diagnostics company group chairman for Europe, Middle East and Africa, was reelected as chairman. Alain Coudray, Medtronic's VP for Cardiac Rhythm Disease Management, Europe and Central Asia, is the new vice chairman. The board is composed of 15 members, including five corporate representatives and seven representatives of individual European country associations

J&J Reshuffles Device Biz Into “Surgical” And “Comprehensive Care” Groups

Johnson & Johnson is restructuring its device and diagnostics units as part of a larger reorganization intended to improve internal collaborations and help identify opportunities beyond its existing businesses, the company says

Related Content

UsernamePublicRestriction

Register

MT025918

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel